Professor Hugh Gallagher
Hugh is a Consultant Nephrologist at Epsom and St Helier NHS trust and a Visiting Professor in the Academic Unit of Primary Care and Population Sciences at the University of Southampton.
He has a longstanding interest in Chronic Kidney Disease and has led and participated in a number of large-scale CKD improvement projects funded by the Health Foundation. Hugh was the clinical lead for a successful bid to the Department of Health for a national clinical audit of CKD management in primary care and has served on the NICE Guideline Development Group and the Quality Standard Advisory Group for CKD and the NICE Guideline Committee for renal replacement therapy.
He co-authored the 2017 National Renal Research Strategy and is currently leading a large (n=23000 patients) randomised clinical trial of aspirin for the primary prevention of cardiovascular disease in CKD funded by the National Institute of Health Research and British Heart Foundation. Hugh's areas of interest include quality improvement, hypertension and cardiovascular disease in CKD, renal disease in diabetes, and proteinuria.